scholarly article | Q13442814 |
P50 | author | Jakob E. Bardram | Q24389216 |
Lars Vedel Kessing | Q27504786 | ||
Maj Vinberg | Q48977784 | ||
Maria Faurholt-Jepsen | Q57043914 | ||
P2093 | author name string | Ellen Margrethe Christensen | |
Mads Frost | |||
P2860 | cites work | Interventions for helping people recognise early signs of recurrence in bipolar disorder | Q24243177 |
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials | Q24614627 | ||
A global measure of perceived stress | Q29547166 | ||
Development of a Rating Scale for Primary Depressive Illness | Q29616244 | ||
A rating scale for mania: reliability, validity and sensitivity | Q29619299 | ||
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration | Q29619618 | ||
Latest maintenance data on lithium in bipolar disorder | Q33188415 | ||
Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data | Q33284508 | ||
Historical perspectives and natural history of bipolar disorder | Q33920209 | ||
The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. | Q33954931 | ||
The Altman Self-Rating Mania Scale | Q34065438 | ||
The longitudinal course of bipolar disorder as revealed through weekly text messaging: a feasibility study | Q34066286 | ||
The internal and external validity of the Major Depression Inventory in measuring severity of depressive states | Q34182012 | ||
What's new? The clinical epidemiology of bipolar I disorder | Q34590018 | ||
Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. | Q35865593 | ||
Measuring cortisol in human psychobiological studies. | Q36630283 | ||
Adherence to antidepressant treatment | Q36691765 | ||
Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder | Q37164845 | ||
Early intervention in bipolar disorders: clinical, biochemical and neuroimaging imperatives | Q37280124 | ||
A critical update on psychological interventions for bipolar disorders | Q37631793 | ||
SCAN. Schedules for Clinical Assessment in Neuropsychiatry | Q37929723 | ||
Assays for urinary biomarkers of oxidatively damaged nucleic acids | Q37986872 | ||
Functional impairment as a predictor of short-term symptom course in bipolar I disorder | Q40104223 | ||
Salivary cortisol in psychoneuroendocrine research: recent developments and applications | Q40681414 | ||
Psychomotor symptoms of depression | Q41300078 | ||
Course of illness in depressive and bipolar disorders. Naturalistic study, 1994-1999. | Q42164355 | ||
Measurement of oxidatively generated base damage in cellular DNA and urine | Q43130633 | ||
"Mixed hypomania" in children and adolescents: is it a pediatric bipolar phenotype with extreme diurnal variation between depression and hypomania? | Q43776101 | ||
SPIRIT 2013: new guidance for content of clinical trial protocols | Q43783134 | ||
What is hypomania? Tetrachoric factor analysis and kernel estimation of DSM-IV hypomanic symptoms | Q44597582 | ||
Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study | Q44671658 | ||
Treatment in a specialised out-patient mood disorder clinic v. standard out-patient treatment in the early course of bipolar disorder: randomised clinical trial | Q44724569 | ||
Psychomotor activity in unipolar and bipolar depressive patients | Q44836555 | ||
Long-term outcome of cognitive impairment in bipolar disorder. | Q45075674 | ||
Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. | Q46037763 | ||
Changes of speech activity in depressed patients under pharmacotherapy | Q46555107 | ||
Morbidity in 303 first-episode bipolar I disorder patients | Q47380861 | ||
Objective assessment of circadian activity and sleep patterns in individuals at behavioural risk of hypomania | Q48391899 | ||
Recurrence in affective disorder. I. Case register study. | Q50897602 | ||
Psychomotor activity in affective states. | Q51305076 | ||
Nonlinear time-series approaches in characterizing mood stability and mood instability in bipolar disorder. | Q51539330 | ||
Prevalence and burden of bipolar disorders in European countries. | Q51929479 | ||
Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S) | Q57602675 | ||
Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment | Q57947248 | ||
[Discovering depression] | Q60445492 | ||
The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders - a life-long perspective | Q60643568 | ||
The effect of comorbid alcoholism on recurrence in affective disorder: a case register study | Q60643577 | ||
Prospective studies on a lithium cohort. 1. General features | Q68034843 | ||
Reliability and validity of the Massachusetts general hospital cognitive and physical functioning questionnaire | Q83355652 | ||
P433 | issue | 7 | |
P921 | main subject | bipolar disorder | Q131755 |
P577 | publication date | 2013-07-24 | |
P1433 | published in | BMJ Open | Q17003470 |
P1476 | title | Daily electronic self-monitoring of subjective and objective symptoms in bipolar disorder--the MONARCA trial protocol (MONitoring, treAtment and pRediCtion of bipolAr disorder episodes): a randomised controlled single-blind trial | |
P478 | volume | 3 |
Q90694870 | A comparative study of engagement in mobile and wearable health monitoring for bipolar disorder |
Q53407108 | A review of physiological and behavioral monitoring with digital sensors for neuropsychiatric illnesses. |
Q88798220 | ATS-PD: An Adaptive Testing System for Psychological Disorders |
Q28597251 | Applications of time-series analysis to mood fluctuations in bipolar disorder to promote treatment innovation: a case series. |
Q47376705 | Associations between mood instability and emotional processing in a large cohort of bipolar patients |
Q33447994 | Behavioral activities collected through smartphones and the association with illness activity in bipolar disorder. |
Q24186638 | Comparison of self-administered survey questionnaire responses collected using mobile apps versus other methods |
Q26770794 | Considerations on assisted resilience and individualized therapy in bipolar affective disorder, with a clinical case exemplification |
Q38243166 | DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, |
Q33442123 | Daily electronic monitoring of subjective and objective measures of illness activity in bipolar disorder using smartphones--the MONARCA II trial protocol: a randomized controlled single-blind parallel-group trial |
Q33446237 | Daily mood monitoring of symptoms using smartphones in bipolar disorder: A pilot study assessing the feasibility of ecological momentary assessment |
Q33830868 | Data Collection for Mental Health Studies Through Digital Platforms: Requirements and Design of a Prototype. |
Q47106509 | Digital Platforms in the Assessment and Monitoring of Patients with Bipolar Disorder. |
Q58112994 | Effectiveness of smartphone-based ambulatory assessment (SBAA-BD) including a predicting system for upcoming episodes in the long-term treatment of patients with bipolar disorders: study protocol for a randomized controlled single-blind trial |
Q26771973 | Electronic self-monitoring of mood using IT platforms in adult patients with bipolar disorder: A systematic review of the validity and evidence |
Q55397284 | Engagement Strategies for Self-Monitoring Symptoms of Bipolar Disorder With Mobile and Wearable Technology: Protocol for a Randomized Controlled Trial. |
Q38991863 | Experiences of remote mood and activity monitoring in bipolar disorder: A qualitative study. |
Q38605673 | Getting to wellness: The potential of the athletic model of marginal gains for the treatment of bipolar disorder |
Q38252641 | Optimizing delivery of recovery-oriented online self-management strategies for bipolar disorder: a review |
Q54361559 | Prognostic models in bipolar disorder: can the prediction of the long-term clinical course rely on the integration of clinical and molecular data? |
Q33451588 | Rationale and protocol for using a smartphone application to study autism spectrum disorders: SMARTAUTISM. |
Q33455104 | Reducing the rate and duration of Re-ADMISsions among patients with unipolar disorder and bipolar disorder using smartphone-based monitoring and treatment - the RADMIS trials: study protocol for two randomized controlled trials |
Q50419933 | Response heterogeneity: Challenges for personalised medicine and big data approaches in psychiatry and chronic pain. |
Q38239842 | Self-management and bipolar disorder--a clinician's guide to the literature 2011-2014. |
Q33443296 | Self-monitoring and psychoeducation in bipolar patients with a smart-phone application (SIMPLe) project: design, development and studies protocols |
Q30995926 | Smartphone data as an electronic biomarker of illness activity in bipolar disorder |
Q33440902 | Strategies for mHealth research: lessons from 3 mobile intervention studies |
Q52305625 | Taking or not taking medications: psychiatric treatment perceptions in patients diagnosed with bipolar disorder. |
Q30434498 | Telemonitoring with respect to mood disorders and information and communication technologies: overview and presentation of the PSYCHE project |
Q92655683 | The True Colours Remote Symptom Monitoring System: A Decade of Evolution |
Q92827078 | The effect of smartphone-based monitoring on illness activity in bipolar disorder: the MONARCA II randomized controlled single-blinded trial |
Q35529231 | The impact of treatment decisions on the diagnosis of bipolar disorders |
Q91695704 | Use of ecological momentary assessment to detect variability in mood, sleep and stress in bipolar disorder |
Q27670216 | Voice analysis as an objective state marker in bipolar disorder |
Q90050151 | What Would Digital Early Intervention for Bipolar Disorder Look Like? Theoretical and Translational Considerations for Future Therapies |
Q38368792 | mHealth Technologies for Palliative Care Patients at the Interface of In-Patient to Outpatient Care: Protocol of Feasibility Study Aiming to Early Predict Deterioration of Patient's Health Status |
Search more.